These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7506375)

  • 41. Classification according to chemical structure, mutagenicity to Salmonella and level of carcinogenicity of a further 42 chemicals tested for carcinogenicity by the U.S. National Toxicology Program.
    Ashby J; Tennant RW; Zeiger E; Stasiewicz S
    Mutat Res; 1989 Jun; 223(2):73-103. PubMed ID: 2662004
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Carcinogenesis. Testing times for the tests.
    Hay A
    Nature; 1991 Apr; 350(6319):555-6. PubMed ID: 2017254
    [No Abstract]   [Full Text] [Related]  

  • 43. Mutagenesis, clastogenesis, carcinogenesis: expectations, correlations and relations.
    Zeiger E; Tennant RW
    Prog Clin Biol Res; 1986; 209B():75-84. PubMed ID: 3529117
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structural analysis and predictive value of the rodent in vivo micronucleus assay results.
    Benigni R; Bossa C; Worth A
    Mutagenesis; 2010 Jul; 25(4):335-41. PubMed ID: 20194420
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A special issue dedicated to Dr. Bruce N. Ames: Introduction.
    Walker GC
    Mutat Res Genet Toxicol Environ Mutagen; 2020 Jan; 849():503115. PubMed ID: 32087846
    [No Abstract]   [Full Text] [Related]  

  • 46. Assessment of the sensitivity of the computational programs DEREK, TOPKAT, and MCASE in the prediction of the genotoxicity of pharmaceutical molecules.
    Snyder RD; Pearl GS; Mandakas G; Choy WN; Goodsaid F; Rosenblum IY
    Environ Mol Mutagen; 2004; 43(3):143-58. PubMed ID: 15065202
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Testing strategies in mutagenicity and genetic toxicology: an appraisal of the guidelines of the European Scientific Committee for Cosmetics and Non-Food Products for the evaluation of hair dyes.
    Kirkland DJ; Henderson L; Marzin D; Müller L; Parry JM; Speit G; Tweats DJ; Williams GM
    Mutat Res; 2005 Dec; 588(2):88-105. PubMed ID: 16326131
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Short-term tests for mutagenesis and carcinogenesis in drug toxicology: how to test and when to test is the question.
    De La Iglesia FA; Lake RS; Fitzgerald JE
    Drug Metab Rev; 1980; 11(1):103-46. PubMed ID: 6448737
    [No Abstract]   [Full Text] [Related]  

  • 49. Statistical analysis of Salmonella test data and comparison to results of animal cancer tests.
    McCann J; Gold LS; Horn L; McGill R; Graedel TE; Kaldor J
    Mutat Res; 1988; 205(1-4):183-95. PubMed ID: 3285186
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of the mutagenicity of chloral hydrate in vitro and in vivo.
    Leuschner J; Leuschner F
    Arzneimittelforschung; 1991 Oct; 41(10):1101-3. PubMed ID: 1799393
    [TBL] [Abstract][Full Text] [Related]  

  • 51. On the need for confirmation of negative genotoxicity results in vitro and on the usefulness of mammalian cell mutation tests in a core battery: experiences of a contract research laboratory.
    Kirkland DJ; Dean SW
    Mutagenesis; 1994 Nov; 9(6):491-501. PubMed ID: 7854139
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genotoxicity of o-aminoazotoluene (AAT) determined by the Ames test, the in vitro chromosomal aberration test, and the transgenic mouse gene mutation assay.
    Ohsawa K; Hirano N; Sugiura M; Nakagawa S; Kimura M
    Mutat Res; 2000 Nov; 471(1-2):113-26. PubMed ID: 11080667
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The MINISCREEN assay.
    Zeiger E
    Mutagenesis; 1996 Jul; 11(4):415,417. PubMed ID: 8671767
    [No Abstract]   [Full Text] [Related]  

  • 54. A decision tree-based integrated testing strategy for tailor-made carcinogenicity evaluation of test substances using genotoxicity test results and chemical spaces.
    Fujita Y; Honda H; Yamane M; Morita T; Matsuda T; Morita O
    Mutagenesis; 2019 Mar; 34(1):101-109. PubMed ID: 30551173
    [TBL] [Abstract][Full Text] [Related]  

  • 55. International Workshop on Standardisation of Genotoxicity Test Procedures. Report of in vivo subgroup.
    Tice RR; Shelby MD
    Mutat Res; 1994 Jun; 312(3):287-92. PubMed ID: 7514740
    [No Abstract]   [Full Text] [Related]  

  • 56. Anomalous nonidentity between Salmonella genotoxicants and rodent carcinogens: nongenotoxic carcinogens and genotoxic noncarcinogens.
    Yoshikawa K
    Environ Health Perspect; 1996 Jan; 104(1):40-6. PubMed ID: 8834860
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The influence of automobile exhausts on mutagenicity of soils: contamination with, fractionation, separation, and preliminary identification of mutagens in the Salmonella/reversion assay and effects of solvent fractions on the sister-chromatid exchanges in human lymphocyte cultures and in the in vivo mouse bone marrow micronucleus assay.
    Wesp HF; Tang X; Edenharder R
    Mutat Res; 2000 Dec; 472(1-2):1-21. PubMed ID: 11113694
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genotoxicity testing of pidotimod in vitro and in vivo.
    Adams K; Allen JA; Brooker PC; Henderson L; Jones E; Proudlock RJ; Mailland F; Coppi G
    Arzneimittelforschung; 1994 Dec; 44(12A):1454-9. PubMed ID: 7857341
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An SAR study of the mutagenicity of PAH compounds in Salmonella typhimurium.
    Moyer SR; Jurs PC
    Prog Clin Biol Res; 1990; 340B():1-10. PubMed ID: 2203000
    [No Abstract]   [Full Text] [Related]  

  • 60. Salmonella/human S9 mutagenicity test: a collaborative study with 58 compounds.
    Hakura A; Shimada H; Nakajima M; Sui H; Kitamoto S; Suzuki S; Satoh T
    Mutagenesis; 2005 May; 20(3):217-28. PubMed ID: 15843387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.